Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senior management changes at Aastrom Biosciences

This article was originally published in Scrip

Executive Summary

Aastrom Biosciences (US) has announced that its CEO, president, chief financial officer and director, George Dunbar, will move out of day-to-day management duties and is expected to assume the role of chairman after the company's annual meeting of shareholders, which is planned for December 14th. Timothy Mayleben, a member of the company's board of directors and chair of the audit committee, will remain as a director and will become the Aastrom's new CEO, president and CFO in December. Nelson Sims, who has served as chairman since October 2008, is expected to assume the role of lead director.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC004341

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel